Genentech, Roche) for adult patients with active lupus nephritis who are receiving standard therapy, marking the first anti-CD20 monoclonal antibody approved for this serious kidney complication of systemic lupus erythematosus
In subjects with T2DM, weekly administration of tirzepatide at doses of 5 mg, 10 mg, or 15 mg was associated with greater weight loss compared to placebo ( 6.3 kg, 8.4 kg, and 9.4 kg, respectively), and 1.7 kg, 4.8 kg, and 7.2 kg greater weight loss compared to selective GLP-1 receptor agonists, demonstrating a dose-dependent effect sustained for up to 2 years [48]
However, germs are still everywhere
Another study found using 2.5% linoleic acid gel for 4 weeks showed a 25% reduction in small comedones
Semaglutide has a deeper safety database
Data and reproducibility All statistical analyses were performed using GraphPad Prism version 7.04 or later